Northern Trust Corp Neogenomics Inc Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,621,809 shares of NEO stock, worth $16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,621,809
Previous 1,510,639
7.36%
Holding current value
$16 Million
Previous $22.3 Million
19.95%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$194 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$140 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$64.2 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$60.7 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$60.6 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.24B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...